Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970107_sep96_decls36_0001.txt
Subject: REQ FOR ANTHRAX AND BOTULINUM VACCINE AND BOTULINUM ANTITOXI
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: REQUEST FOR ANTHRAX AND BOTULINUM VACCINE AND BOTULIN
Document Number: 1
Folder Seq #: 53
UNCLASSIFIED
fC r. P. P F.:L
14)LUIIL I
DEPARTMENT OF THE ARMY
OFFICE OF THE SURGEON GENERAL
5109 LEESBURG PIKE
FALLS CHURCH. VA 22041-3258
RRPLY TO
ATTENTION OF
S: 12 Apr 91
DASG-HCD-,D (50k)
MEMORANDUM FOR HQUSAF/SGHR, BOLLING AFB DC 20332-6188
SUBJECT: Request for Anthrax and Botulinum Vaccine and Botulinum
Antitoxin Recfuirements
1. Although anthrax and botulinum vaccine production was in
progress before operation Desert Shield, production rates and
stockpiles were inadequate to meet the services, requirements. The
services were involved in numerous briefings to the Joint Chiefs of
Staff on Biological Warfare Vaccination Issues and Deficiencies.
Finally, on 2 Jan 91 a decision was 'made to execute the Medical
Biological Warfare Vaccination Program in the AOR even though there
were insufficient vaccines to immunize the total force. In
addition there very few doses of botulinum antitoxin to treat
botulinum casualties.
2. @ To be better prepared to deal with future biological
warfare threats, recommend that a contingency vaccine and antitoxin
stockpile be established to meet services' requirements. Also
designated early deploying forces should be vaccinated during
peacetime. This information as generated by the services will be
compiled and incorporated into the Medical Biological Warfare
Defense Plan stating the services' position to and requesting
Affairs.
3. @ Request the following information to assist in development
of the services' Medical Biological Warfare Defense Plan:
a. (U) The total force strength requiring vaccination in
future mobilizations.
b. (U) The size of the early deploying force which will
r @ ire immunization during peacetime.
C. T* It is assume that the dose requirement for botulinura
antitoxin is of paragraph 3a 'because it will be used to
treat botulinum casualties. The industrial base can be geared up
to produce more if necessary.
DECLASSIFIED
ON: 23 DEC 96
CLASSIFIED BY: MULTIPLE SOURCES BY: SEC ARMY (DAMH) UNDER
DECLASSIFY ON: OADR SEC 3.4 EO 12958
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 4 f:/Week-36/BX003203/REQUEST FOR ANTHRAX AND BOTULINUM VACCINE AND BOTULIN/req for anthrax and botulinum vaccine and botuli:01029715472937
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = REQUEST FOR ANTHRAX AND BOTULINUM VACCINE AND BOTULIN
Folder Seq # = 53
Subject = REQ FOR ANTHRAX AND BOTULINUM VACCINE AND BOTULI
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997